| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 1339-1340 |
| Journal | Journal of Clinical Oncology |
| Volume | 27 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 2009 |
Cite this
van der Veldt, A. A. M., Boven, E., Vroling, L., Broxterman, H. J., van den Eertwegh, A. J. M., & Haanen, JB. (2009). Sunitinib-Induced Hemoglobin Changes Are Related to the Dosing Schedule. Journal of Clinical Oncology, 27(8), 1339-1340. https://doi.org/10.1200/JCO.2008.20.6151
@article{cb3e3769153c44daa0c45b5a5026025c,
title = "Sunitinib-Induced Hemoglobin Changes Are Related to the Dosing Schedule",
author = "{van der Veldt}, A.A.M. and E. Boven and L. Vroling and H.J. Broxterman and {van den Eertwegh}, A.J.M. and JB Haanen",
year = "2009",
doi = "10.1200/JCO.2008.20.6151",
language = "Undefined/Unknown",
volume = "27",
pages = "1339--1340",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "8",
}
van der Veldt, AAM, Boven, E, Vroling, L, Broxterman, HJ, van den Eertwegh, AJM & Haanen, JB 2009, 'Sunitinib-Induced Hemoglobin Changes Are Related to the Dosing Schedule' Journal of Clinical Oncology, vol. 27, no. 8, pp. 1339-1340. https://doi.org/10.1200/JCO.2008.20.6151
Sunitinib-Induced Hemoglobin Changes Are Related to the Dosing Schedule. / van der Veldt, A.A.M.; Boven, E.; Vroling, L.; Broxterman, H.J.; van den Eertwegh, A.J.M.; Haanen, JB.
In: Journal of Clinical Oncology, Vol. 27, No. 8, 2009, p. 1339-1340.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Sunitinib-Induced Hemoglobin Changes Are Related to the Dosing Schedule
AU - van der Veldt, A.A.M.
AU - Boven, E.
AU - Vroling, L.
AU - Broxterman, H.J.
AU - van den Eertwegh, A.J.M.
AU - Haanen, JB
PY - 2009
Y1 - 2009
U2 - 10.1200/JCO.2008.20.6151
DO - 10.1200/JCO.2008.20.6151
M3 - Article
VL - 27
SP - 1339
EP - 1340
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
SN - 0732-183X
IS - 8
ER -
van der Veldt AAM, Boven E, Vroling L, Broxterman HJ, van den Eertwegh AJM, Haanen JB. Sunitinib-Induced Hemoglobin Changes Are Related to the Dosing Schedule. Journal of Clinical Oncology. 2009;27(8):1339-1340. https://doi.org/10.1200/JCO.2008.20.6151